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1Primary percutaneous coronary intervention (PCI) is the preferred method of revascularization for acute 
ST-segment–elevation myocardial infarction (STEMI).1 For 
patients undergoing primary PCI, clinical guidelines recom-
mend a first medical contact (FMC)-to-device time of <90 
minutes for patients presenting to a PCI-capable hospital and 
<120 minutes for patients presenting to a non-PCI-capable 
hospital.1 However, ≈30% to 50% of patients are not reper-
fused within those timeframes.2–5 This cannot be completely 
explained by inadequate access because 90% of Americans 
live within 60 minutes of PCI-capable hospitals, and this 
figure continues to grow at a rate exceeding that of the US 
Background—The Mission: Lifeline STEMI Systems Accelerator program, implemented in 16 US metropolitan regions, 
resulted in more patients receiving timely reperfusion. We assessed whether implementing key care processes was 
associated with system performance improvement.
Methods and Results—Hospitals (n=167 with 23 498 ST-segment–elevation myocardial infarction patients) were surveyed 
before (March 2012) and after (July 2014) program intervention. Data were merged with patient-level clinical data over the 
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median first medical contact-to-device times (112 versus 128 versus 152 minutes; P<0.001). Emergency department 
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population.6–9 The challenges in meeting target reperfusion 
times are often because of system issues that hinder coordi-
nation between emergency medical service (EMS) providers 
and hospitals and competition among hospitals and integrated 
physician groups.10
The American Heart Association Mission: Lifeline STEMI 
Systems Accelerator program was developed and implemented 
in 16 US metropolitan regions to organize leadership, develop 
common protocols, and initiate ongoing data collection and 
timely review to improve the proportion of patients receiving 
timely coronary intervention.10 This program significantly but 
modestly increased the overall proportion of patients meet-
ing guideline goals for FMC-to-device times both for patients 
presenting directly to a PCI-capable hospital and those trans-
ferred from non-PCI-capable hospitals.10a
Few studies have compared the impact of multiple STEMI 
patient flow care processes on reperfusion times.11–14 To our 
knowledge, no prior studies have determined the specific 
impact on systems performance of rapidly implementing care 
processes across multiple heterogeneous STEMI systems as 
part of a large-scale, national effort. Therefore, the goal of the 
current study was to (1) determine the uptake of recommended 
care processes and protocols across hospitals using a pre- and 
postimplementation survey as part of a large-scale national 
effort to regionalize STEMI care and (2) determine whether 
hospitals implementing one of 4 specific key care processes 
had shorter reperfusion times versus those that did not.
Methods
The STEMI Accelerator intervention was organized and executed 
between March 2012 and July 2014 in 171 hospitals and 23 809 
patients, as previously described.10,14 Each region identified a 
baseline quarter as the preintervention period, with the remaining 
quarters considered the postintervention period. Project initiation 
was conducted on a rolling basis over 6 months, and each region 
specified a quarter (quarters 3 or 4, 2012; or quarter 1, 2013) as the 
baseline from which to assess subsequent temporal trends in out-
comes. The following 16 of 21 regions that applied for participation 
in the project met enrollment criteria by the baseline data collection 
quarter and were included: Atlanta, GA; Columbus, OH; Denver, 
CO; Hartford, CT; Houston, TX; Kern County, CA; Louisville, KY; 
New York City, NY; Northern New Jersey; Oklahoma City, OK; 
Philadelphia, PA; Pittsburgh, PA; St. Louis, MO; San Antonio, TX; 
Tampa, FL; and Wilkes-Barre/Scranton, PA. All hospitals within 
participating regions were enrolled in the National Cardiovascular 
Data Registry ACTION Registry-GWTG program (Acute Coronary 
Treatment and Intervention Outcomes Network Registry-Get With 
The Guidelines), described in more detail below.15 Each region 
developed common protocols for STEMI care based on guideline 
recommendations. A detailed description of the protocol has been 
published previously.10 All patients with ongoing ischemic symp-
toms lasting for >10 minutes but <12 hours and who had ECG-
diagnosed ST-segment–elevation or left bundle-branch block were 
included. In cases where the first ECG did not have diagnostic ST-
segment–elevation, FMC-to-device time was reset to the time of the 
first diagnostic ECG.
Reperfusion and Outcomes Data
The ACTION Registry-GWTG15 is a voluntary quality improvement 
registry in the United States that includes consecutive patients ad-
mitted to participating hospitals with STEMI or non-STEMI. This 
program is sponsored by the American College of Cardiology and 
the American Heart Association. Definitions for data elements of 
the registry are available at https://www.ncdr.com/webncdr/action/
home/datacollection. The National Cardiovascular Data Registry 
data quality program includes data abstraction training, data qual-
ity thresholds for inclusion, site data quality feedback reports, in-
dependent auditing, and data validation. An audit of the data has 
demonstrated chart review agreement in >93% of patients.16 At par-
ticipating sites, this registry was either approved by an institutional 
review board or considered quality assurance data and was, there-
fore, not subject to institutional review board approval based on in-
dividual site determinations. The Duke Clinical Research Institute 
serves as the data coordinating center to analyze deidentified data 
for research purposes.
Pre- and Postimplementation Survey
American Heart Association Mission: Lifeline coordinators at each 
participating hospital were contacted via mail or phone to answer 
a series of questions related to STEMI processes of care and oth-
er hospital procedures (Supplement S1 in the Data Supplement). 
Respondents answered each question at 2 different time points: (1) 
prior to implementation of STEMI regionalization (preintervention, 
quarter 1: region-dependent, but typically between July to September 
or October to December 2012) and (2) after implementation of 
STEMI regionalization (postintervention, after quarter 7: July to 
September 2014).
For the purpose of analyzing the relationship between the uptake 
of 4 key STEMI care processes and reperfusion times, hospitals were 
stratified according to pre- and postintervention survey responses: (1) 
hospitals that did not have the care process in place at baseline, but 
subsequently implemented the existing care process postintervention; 
(2) hospitals that had an existing care process in place at baseline; and 
(3) hospitals that did not have the care process in place at baseline and 
did not implement postintervention. The 4 care processes evaluated 
were the following:
• Prehospital cardiac catheterization laboratory activation 
for patients presenting directly via EMS to a PCI-capable 
hospital.
• Single call primary PCI transfer protocol for patients present-
ing to a non-PCI-capable hospital.
WHAT IS KNOWN
• Few studies have compared the impact of mul-
tiple ST-segment–elevation myocardial infarction 
(STEMI) patient flow care processes on reperfusion 
times.
• No prior studies have determined the specific impact 
on system performance of rapidly implementing care 
processes across multiple heterogeneous STEMI 
systems at a national level.
WHAT THE STUDY ADDS
• Through the American Heart Association STEMI 
Systems Accelerator Project, the first effort to re-
gionalize STEMI care nationally, we found that 
hospitals implementing key care processes (preac-
tivation, single call transfer, emergency department 
bypass for both direct emergency medical service 
presenters and transfers) had shorter reperfusion 
times compared with hospitals that did not imple-
ment these processes.
• Our results support efforts to continue to optimize 
STEMI systems, with a focus on these key care 
processes.
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• Emergency department (ED) bypass for patients presenting di-
rectly via EMS to a PCI-capable hospital (bypass was defined 
as <5 minutes in the ED).
• ED bypass for patients transferred from a non-PCI-capable 
hospital to a PCI-capable hospital (with bypass again defined 
as <5 minutes in the ED).
Out of 171 STEMI Accelerator PCI-capable hospitals in 16 re-
gions, 167 (97%) hospitals completed and returned the care processes 
survey. No outcomes data were revealed or known to the investigators 
until all the survey data were collected. Patient-level data, including 
reperfusion times, were linked to specific hospitals using American 
Hospital Association numbers. The overall study flow chart is shown 
in Figure 1.
Statistical Analysis
Descriptive statistics for continuous and categorical variables were 
described as medians (interquartile ranges) and numbers (percent-
ages), respectively. Patient characteristics and process measures 
were compared by use of the Wilcoxon rank-sum test for 2-group 
comparisons (the Kruskal–Wallis test was used for comparisons 
of >2 groups) and Pearson’s χ2 or Fisher’s exact tests as appropri-
ate. A multivariable logistic regression model was used to estimate 
the adjusted odds ratio and 95% confidence interval for in-hospital 
mortality outcome based on variables found to be predictive of in-
hospital mortality in the ACTION Registry-GWTG risk score17: age, 
baseline creatinine, systolic blood pressure, initial troponin, heart 
failure on presentation, cardiogenic shock on presentation, heart 
rate, and a history of peripheral artery disease. In addition to the 
above variables, out-of-hospital cardiac arrest, a strong predictor of 
in-hospital mortality in ACTION-Registry GWTG hospitals,18 was 
also included in the model. FMC-to-device time data were presented 
and summarized graphically using mountain plots, which represent 
a folded-empirical distribution function curve of the data at the 50th 
percentile (median).19
All statistical tests were conducted at the 0.05 significance 
level. Statistical analyses were performed with SAS version 9.2 or 
higher (SAS Institute Inc, Cary, NC). The project was reviewed by 
the Duke University Institutional Review Board and classified as 
exempt.
Results
Pre- and Postimplementation Survey
In the 167 hospitals surveyed, uptake of each of the 4 key 
processes increased after intervention (Figure 2): prehospital 
activation (62%–91%; P<0.001), single call transfer proto-
col (45%–70%; P<0.001), and ED bypass for direct present-
ers (48%–59%; P=0.002) and transfer patients (56%–79%; 
P=0.001). Uptake of most other care processes also increased 
after intervention (Supplement S2 in the Data Supplement).
Patient Characteristics and Presentation
Between 2012 quarter 3 and 2014 quarter 1 (7 quarters), 
23 809 patients presented with acute STEMI, including 18 267 
patients who presented directly to a PCI-capable hospital and 
5542 who were transferred from hospitals without PCI capa-
bility. Among those presenting to PCI-capable hospitals, 64% 
(n=11 765) were transported by EMS providers, while 36% 
(n=6502) arrived by self-transport.14 For the current analysis, 
overall patient clinical characteristics did not change between 
quarter 1 and quarter 7 (Table 1), with some exceptions. Com-
pared with quarter 1, patients in quarter 7 were more likely 
to be male (72.2% versus 70.0%; P=0.044), insured through 
Medicaid (11.0% versus 9.2%; P=0.03), and considered a 
reperfusion candidate (96.6% versus 93.9%; P<0.0001), but 
these patients were less likely to have prior heart failure (2.7% 
versus 3.5%; P=0.025).
Reperfusion Times for Key STEMI Care Processes
There were significant differences in median FMC-to-device 
times among patients treated at hospitals that implemented 
preactivation for EMS transport to a PCI-capable hospital 
compared with nonimplementers (88 minutes for implement-
ers versus 89 minutes for preexisting versus 98 minutes for 
Figure 1. Study flow chart. ED indicates 
emergency department; FMC, first medi-
cal contact; GWTG, Get With The Guide-
lines; and PCI, percutaneous coronary 
intervention.
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nonimplementers; P<0.001 for group comparisons; Fig-
ure 3A). Similarly, patients treated at hospitals implementing 
single call transfer protocols at non-PCI-capable hospitals had 
shorter median FMC-to-device times (112 versus 128 versus 
152 minutes; P<0.001). ED bypass was also associated with 
shorter FMC-to-device times for both direct presenters (84 
versus 88 versus 94 minutes; P<0.001) and transfers (123 ver-
sus 127 versus 167 minutes; P<0.001; Figure 3B).
In-Hospital Mortality
After adjustment for 9 variables associated with increased 
in-hospital mortality (ACTION Risk Score+cardiac arrest), 
we found no statistically significant difference in mortal-
ity between hospitals for any of the 4 key care processes 
of preactivation, single call transfer protocol, or ED bypass 
for both direct presenters and transfers (Table 2). How-
ever, hospitals that implemented all 4 care processes by 
the end of the STEMI Accelerator program (or had them 
preexisting) had numerically lower in-hospital mortality 
(6.0%) compared with those implementing only 1 (6.2%), 2 
(6.3%), or 3 (7.3%) processes (Supplemental S3 in the Data 
Supplement).
Discussion
The overall goal of this study was to determine the impact 
of rapidly implementing care processes across multiple het-
erogeneous STEMI systems as part of a large scale, national 
effort. We found that after implementation of the STEMI 
Accelerator program, there was a significant uptake in sev-
eral care processes. Importantly, we found that hospitals 
implementing the key care processes of prehospital activa-
tion of a cardiac catheterization laboratory, single call trans-
fer protocol from an non-PCI-capable facility, or ED bypass 
for both direct EMS presenters or transfers had shorter 
median reperfusion times compared with hospitals that did 
not implement these processes and comparable reperfusion 
times compared with hospitals that had the process in place 
at baseline.
Our work extends that of prior observational studies, 
which found associations between STEMI care processes 
and improved reperfusion times, including preactivation of 
the cardiac catheterization laboratory,20 interfacility transfer 
for primary PCI,5 and ED bypass.3,4 Some smaller studies 
have compared the impact of STEMI patient flow care pro-
cess intervention on outcomes, such as reperfusion times and 
infarct size.11–13 However, to our knowledge, this is the first 
study to demonstrate the specific impact on systems perfor-
mance of rapidly implementing care processes across mul-
tiple heterogeneous STEMI systems on such a large-scale 
basis, involving nearly one quarter of all STEMI patients in 
the United States during this study time period. Furthermore, 
by merging hospital-level care process data with patient-
level data on reperfusion times, we are able to demonstrate 
that efforts at implementation were associated with modest 
reductions in reperfusion times using the most contempo-
rary, guideline-recommended reperfusion metric, FMC-to-
device time.
This study has several important implications. First, we 
show that STEMI systems may be rapidly implemented with 
data collection, feedback, multidisciplinary team engage-
ment, and importantly, adopting specific key care processes. 
Second, times to reperfusion in systems implementing pro-
cesses were comparable to those with preexisting processes. 
This provides a critical and positive message for regions who 
have not yet adopted formalized reperfusion protocols, dem-
onstrating that system performance can improve in a timely 
fashion. As a corollary, our data also demonstrate that hospi-
tals that do not implement key STEMI care processes continue 
to have the longest reperfusion times. Further, the overall pro-
gram costs are relatively modest at $USD 1.9 million for the 
additional resources to implement regionalization across all 
study regions. This translates into a cost per patient of ≈$USD 
80 ($1 900 000/23 809 STEMI patients in Accelerator). We 
think that this additional expense is fairly modest on a per-
patient basis compared with the total cost of a single hospi-
talization for STEMI patients, recently reported to range from 
$23 000 to $28 000 based on Nationwide Inpatient Sample 
data.21 Overall, these data support efforts to optimize STEMI 
systems, with ongoing focus on the key processes to reduce 
FMC-to-device times.
Figure 2. Uptake of 4 key care 
processes across 167 hospitals 
during the STEMI accelerator 
program. ED indicates emer-
gency department; and STEMI, 
ST-segment–elevation myocardial 
infarction.
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There are some limitations. The survey results were 
reported by representatives in regions, whereby all hospitals 
were participating in the ACTION Registry-GWTG and, thus, 
may be at risk for both reporting and selection bias. However, 
this strategy to assess care process implementation was inde-
pendent of reperfusion time reporting, which was captured 
by the ACTION Registry-GWTG; therefore, the findings 
that care process implementation was associated with shorter 
reperfusion times are likely robust. We also focused on 4 key 
care processes and others not studied or yet to be analyzed 
may be important to reduce reperfusion times. However, 
these care processes were specifically chosen to be impor-
tant determinants of system performance3,5,10,20 and highly 
modifiable at a hospital and regional level; we now extend 
these findings to a national level. We have limited power to 
evaluate subgroups based on individual processes because 
of unmeasured or unmeasurable system factors, as well as a 
lack of power to reliably assess impact on mortality, which 
was neutral in this study. With relatively smaller sample 
sizes and observational data, it may be unrealistic to expect 
a significant change in overall mortality during a relatively 
short follow-up period, particularly when some systems of 
care were already functioning well at baseline.14,22 Finally, we 
are unable to adequately compare the relative benefit of each 
care process over another because hospitals may have used 
>1 care process at a time.
The neutral mortality results may also be related to secu-
lar trends demonstrating increasing mortality risk in contem-
porary STEMI populations,23,24 which could then offset gains 
in patients with shorter reperfusion times (survivor–cohort 
effect).25 We found numeric (but not statistically significant) 
increases in both shock (7.5%–8.4%) and cardiac arrest 
(7.3%–8.1%) at presentation between quarters 1 and 7, sug-
gestive of a temporal increase in risk among STEMI patients 
within our study (Table 1). While we were unable to demon-
strate a mortality benefit associated with shorter reperfusion 
times at the population level, the benefit of shorter reperfu-
sion times to decrease mortality at the individual patient level 
is still clear.26 As discussed earlier, our study may be under-
powered to show a mortality benefit in our population or lon-
ger follow-up may be required to demonstrate the impact of 
Table 1. Patient Characteristics for All STEMI Patients: 
Quarter 1 Versus Quarter 7
Characteristic
Quarter 1 
(N=3477)
Quarter 7 
(N=3311) P Value
Median age, y 61.0 (52.0–70.0) 60.0 (52.0–70.0) 0.72
Male sex 2433 (70.0%) 2391 (72.2%) 0.044
Race   0.22
  White 2913 (83.8%) 2724 (82.3%)  
  Black 375 (10.8%) 381 (11.5%)  
  Other 189 (5.4%) 206 (6.2%)  
Latino ethnicity 358 (10.3%) 323 (9.8%) 0.47
Insurance
  Private/HMO 1912 (55.0%) 1860 (56.2%) 0.64
  Medicaid 321 (9.2%) 363 (11.0%) 0.03
  None 565 (16.2%) 505 (15.3%) 0.27
  Other 707 (20.3%) 632 (19.1%) 0.20
Prior myocardial 
infarction
376 (10.8%) 416 (12.6%) 0.11
Prior heart failure 123 (3.5%) 90 (2.7%) 0.02
Prior PCI 443 (12.7%) 441 (13.3%) 1.00
Prior coronary 
bypass surgery
132 (3.8%) 121 (3.7%) 0.52
Diabetes mellitus 919 (26.4%) 876 (26.5%) 0.98
Median symptom 
onset to FMC 
(minutes)
69.0 (31.0–172.0) 68.5 (31.5–167.5) 0.58
Shock on 
presentation
262 (7.5%) 278 (8.4%) 0.19
Cardiac arrest 253 (7.3%) 267 (8.1%) 0.25
Heart failure on 
presentation
239 (6.9%) 222 (6.7%) 0.81
Reperfusion 
candidate
3264 (93.9%) 3200 (96.6%) <0.0001
Median heart rate 
on presentation, 
bpm
80.0 (66.0–93.0) 80.0 (66.0–93.0) 0.21
Median systolic 
blood pressure, 
mm Hg
140.0 (119.0–
160.0)
140.0 (120.0–
163.0)
0.37
STEMI first 
diagnosed
  0.81
  First ECG 3403 (97.9%) 3233 (97.6%)  
  Subsequent 46 (1.3%) 50 (1.5%)  
Procedures during hospitalization
  PCI 3096 (89.0%) 2982 (90.1%) 0.18
  Coronary bypass 
surgery
142 (4.1%) 137 (4.1%) 0.95
Complications
  In-hospital 
death
195 (5.6%) 198 (6.0%) 0.51
  Stroke 18 (0.5%) 26 (0.8%) 0.17
  Cardiogenic 
shock
267 (7.7%) 254 (7.7%) 1.00
  Congestive 
heart failure
212 (6.1%) 202 (6.1%) 1.00
  Major bleeding 152 (4.4%) 158 (4.8%) 0.45
  Reinfarction 32 (0.9%) 24 (0.7%) 0.42
Not treated 224 (6.4%) 229 (6.9%) 0.44
Data presented as n (%) or median (interquartile range). ECG indicates 
electrocardiogram; FMC, first medical contact-to-device time; HMO, health 
maintenance organization; PCI, percutaneous coronary intervention; and STEMI, 
ST-segment–elevation myocardial infarction.
Table 1. Continued
Characteristic
Quarter 1 
(N=3477)
Quarter 7 
(N=3311) P Value
(Continued )
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implementing such care processes. We did find a numerically 
lower in-hospital mortality among hospitals that had imple-
mented all 4 care processes by the end of the Accelerator 
program, compared with those that had implemented 1 to 3 
processes (Supplement S3 in the Data Supplement). However, 
a dose–response trend was not observed between number of 
processes and mortality; therefore, these results should be 
interpreted with caution.
In conclusion, this study found that the rapid uptake of 
several care processes occurred during STEMI Accelerator 
implementation across multiple STEMI systems within the 
United States. The implementation of key care processes 
(preactivation, single call transfer, ED bypass for both direct 
EMS presenters and transfers) was associated with improved 
reperfusion times. Efforts to optimize STEMI systems should 
continue and with a focus of these key care processes.
Figure 3. Mountain (folded cumulative distribution at the 50th percentile) plots of first medical contact-to-device times (FMC) according to 
hospital implementation of prehospital cardiac catheterization activation and single call transfer protocol (A) and emergency department 
(ED) bypass for patients presenting directly to a percutaneous coronary intervention (PCI)–capable hospital via emergency medical ser-
vices or those transferred from a non-PCI-capable hospital to a PCI-capable hospital for primary PCI (B). The peak of each mountain plot 
represents the median reperfusion time (50th percentile, in minutes) for patients in that cohort.
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